Assessing national cervical cancer screening guidelines: Results from an HIV testing clinic also screening for cervical cancer and HPV in Soweto, South Africa.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
06
04
2021
accepted:
09
07
2021
entrez:
30
7
2021
pubmed:
31
7
2021
medline:
4
11
2021
Statut:
epublish
Résumé
A screening centre in Soweto, South Africa (SA), investigated high-risk human papillomavirus (HR-HPV), HIV, cervical cancer risk amongst women. This cross-sectional study (June 2018-March 2019) describes screening results (Roche Linear Array HPV test and Pap smear liquid based cytology) and history of screening (known HIV status, antiretroviral therapy [ART] use, previous Pap smears). Data were stratified by age group (18-29, 30+ years), HIV status, Pap smear results and tested for statistical significance. Of 280 women, 20.4% were HIV-positive, 18.2% had abnormal Pap smears, 41.8% had HR-HPV. Of older women, 48.2% (n = 78/162) had never had a Pap smear. Of younger women, 89.0% (n = 105/118) never had a Pap smear, but had significantly more low-grade squamous intraepithelial lesions (LSIL) and other HR-HPV infection than older women (12.7%[n = 15/118] vs 4.9%[n = 8/162], p = 0.0193; and 49.2%[n = 58/118] vs 29.0%[n = 47/162], p = 0.0006; respectively). HIV-positive women had more abnormal cytology results and infection with other HR-HPV types or co-infection with other HR-HPV type(s)/HPV-16 compared to HIV-negative women (35.1%[n = 20/57] vs 13.9%[n = 31/223], p = 0.0002; 56.1%[n = 32/57] vs 32.7%[n = 73/223], p = 0.001; and 12.3%[n = 7/57] vs 4.9%[n = 11/223], p = 0.044; respectively). Of 57 HIV-positive women, 45.6% (n = 26) already knew their HIV status; of which 69.2% were on ART and 34.6% never had a Pap smear. South African women have high rates of HIV, Pap smear abnormalities and HR-HPV, with low cervical cancer screening coverage. SA cervical cancer screening policy excludes (undiagnosed) HIV-positive and HIV-negative women <30 years, both populations found to have high prevalence of HR-HPV. HPV-based primary screening from 25 years could improve outcomes.
Identifiants
pubmed: 34329334
doi: 10.1371/journal.pone.0255124
pii: PONE-D-21-11270
pmc: PMC8323926
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0255124Subventions
Organisme : PEPFAR
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Drugs Ther Perspect. 2020 Aug 9;:1-3
pubmed: 32837195
Curr HIV/AIDS Rep. 2015 Jun;12(2):256-61
pubmed: 25929959
J Natl Cancer Inst. 2020 Oct 1;112(10):1030-1037
pubmed: 32091596
BMJ Evid Based Med. 2018 Oct;23(5):165-168
pubmed: 30054374
J Low Genit Tract Dis. 2020 Apr;24(2):102-131
pubmed: 32243307
PLoS One. 2021 May 14;16(5):e0251688
pubmed: 33989331
IUBMB Life. 2002 Apr-May;53(4-5):253-8
pubmed: 12121005
S Afr Med J. 2013 May;103(5):313-7
pubmed: 23971121
PLoS One. 2013;8(1):e53494
pubmed: 23326441
Glob Health Sci Pract. 2018 Oct 4;6(3):425-438
pubmed: 30143561
J Clin Virol. 2018 Jan;98:37-42
pubmed: 29241150
Vaccine. 2013 Dec 29;31 Suppl 5:F32-46
pubmed: 24331746
Syst Rev. 2018 Nov 17;7(1):198
pubmed: 30447695
Int J Cancer. 2009 Feb 1;124(3):516-20
pubmed: 18973271
AIDS. 2018 Jul 1;32 Suppl 1:S5-S20
pubmed: 29952786
Prev Med. 2015 Aug;77:181-5
pubmed: 26051197
PLoS One. 2018 Jan 2;13(1):e0190166
pubmed: 29293566
S Afr Med J. 2014 Mar;104(3 Suppl 1):249-51
pubmed: 24893502
J Clin Microbiol. 2008 Dec;46(12):4109-10
pubmed: 18945842
Lancet. 2014 Feb 8;383(9916):524-32
pubmed: 24192252
Vaccine. 2012 Nov 20;30 Suppl 5:F88-99
pubmed: 23199969